Crossmark

Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney disease

Crossref DOI link: https://doi.org/10.1186/s12879-019-4010-7

Published Online: 2019-05-02

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saito, Nayuta

Yoshii, Yutaka https://orcid.org/0000-0001-7908-7986
Kaneko, Yugo

Nakashima, Akio

Horikiri, Tsugumi

Saito, Zenya

Watanabe, Sho

Kinoshita, Akira

Saito, Keisuke

Kuwano, Kazuyoshi
License Information

Text and Data Mining valid from 2019-05-02
More Information

Article History

Received: 22 January 2018

Accepted: 22 April 2019

First Online: 2 May 2019

Ethics approval and consent to participate

: This study was approved by the ethics committee of Jikei University School of Medicine [No. 27–031(7938)]. Informed consent was waived by the ethics committee because we retrospectively collected data without using identifying information or applying any interventions.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below